Research published in PLoS Neglected Tropical Diseases suggested that commercially available serological tests for visceral leishmaniasis in Brazil vary significantly in their accuracy.
One of the strategies of Brazil’s national program to reduce mortality associated with visceral leishmaniasis (VL) is the use of serology tests, but these results suggest that this recommendation “needs to be qualified with specific information about the test performance,” Mariana Lourenco Freire, from the Oswaldo Cruz Foundation in Brazil, and colleagues wrote. “There is no consensus about the minimum sensitivity and specificity rates required for a VL diagnostic test.”
This activity is supported by an educational grant from Merck & Co., Inc.
Zika Resource Center
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.